Advertisement
New Zealand markets close in 1 hour 21 minutes
  • NZX 50

    11,835.29
    -111.14 (-0.93%)
     
  • NZD/USD

    0.5958
    +0.0009 (+0.14%)
     
  • NZD/EUR

    0.5554
    +0.0014 (+0.25%)
     
  • ALL ORDS

    7,847.30
    -90.20 (-1.14%)
     
  • ASX 200

    7,585.50
    -97.50 (-1.27%)
     
  • OIL

    83.82
    +0.25 (+0.30%)
     
  • GOLD

    2,345.40
    +2.90 (+0.12%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,628.41
    +343.87 (+1.99%)
     
  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     
  • NZD/JPY

    92.9520
    +0.4560 (+0.49%)
     

Exor N.V.: Periodic Report on the Buyback Program

EXOR N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the second tranche of the share buyback program of up to €250 million announced on 29 July 2022 (the “second tranche”), the Company has completed the following transactions on Euronext Amsterdam:

Trading Date

Number of ordinary shares purchased

Average price per share excluding fees (€)

Total consideration excluding fees (€)

1 December 2022

7,413

76.4983

567,081.90

2 December 2022

30,539

76.1906

2,326,784.73

TOTAL

37,952

 

2,893,866.63

After these purchases, the total invested amount under the second tranche is approximately €116.6 million for a total amount of 1,766,419 ordinary shares purchased.

As of 2 December 2022, the Company held in total 12,563,600 ordinary shares in treasury (5.21% of total ordinary issued share capital).

ADVERTISEMENT

A comprehensive overview of the transactions carried out under the share buyback program, as well as the details of the above transactions, are available on Exor’s corporate website under the Share Buyback section.

Attachment